Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Qpex spins off from TMC, raises $33mm in Series A round
25 Oct 2018
Qpex Biopharma Inc. spun off from the The Medicines Co. (TMC) raising $33mm in its Series A financing led by New Enterprise Associates, which was joined by Adams Street Partners, LYZZ Capital, Hatteras Venture Partners, and Stanford University Draper Fund. According to the Form D, ten investors participated.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?